|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|||||||||||||||||||||||||||||||||||||||||
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||||||||||||||||||||||||||||||
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||||||||||||||||||||||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||||||||||||||||||||||||||||||||||
|
|
Hologic To Present At The C.E. Unterberg, Towbin Life Sciences Conference BEDFORD, Mass. (October 26, 2006) - Hologic, Inc. (NASDAQ: HOLX) today announced that Jack Cumming, Chairman and Chief Executive Officer, and Glenn Muir, Chief Financial Officer, will be presenting at the C.E. Unterberg, Towbin Life Sciences Conference being held October 30 - 31, 2006 at the Palace Hotel in New York. Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation on Monday, October 30, 2006 at 9:30 a.m. Eastern Time on the investor section of the Company's website at www.hologic.com/investor. A replay of the webcast will be available approximately three hours following the presentation. About HologicHologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of innovative imaging technology for digital radiography and breast imaging. Hologic's core business units are focused on mammography and breast biopsy, osteoporosis assessment, and mini C-arm and extremity MRI imaging for orthopedic applications.
|
||||||||||||||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||||||||||||||
| Home | Women's Health | R2 CAD | Suros Surgical | Skeletal Health | OEM Solutions | Customer Care Center | |||||||||||||||||||||||||||||||||||||||||
| Learning
Center | News & Events | Investor
Relations | About Hologic More Information | Locate Us | Terms of Use | Privacy Policy Copyright 2007 Hologic, Inc. All Rights Reserved. |
|||||||||||||||||||||||||||||||||||||||||